58 related articles for article (PubMed ID: 20486162)
1. Dying to predict outcome.
Hogan LE; Raetz EA
Pediatr Blood Cancer; 2010 Jul; 55(1):5-6. PubMed ID: 20486162
[No Abstract] [Full Text] [Related]
2. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
Choi J; Hwang YK; Sung KW; Kim DH; Yoo KH; Jung HL; Koo HH
Leuk Res; 2006 Aug; 30(8):1019-25. PubMed ID: 16388850
[TBL] [Abstract][Full Text] [Related]
3. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
[No Abstract] [Full Text] [Related]
4. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
5. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
6. Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia.
Scrideli CA; de Paula Queiróz R; Bernardes JE; Defavery R; Valera ET; Tone LG
Leuk Res; 2006 Aug; 30(8):1049-52. PubMed ID: 16406015
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling: a possible tool in the prediction of outcome in paediatric acute lymphoblastic leukaemia?
Lanciotti M; D'Apolito M; Paolucci P; Indaco S; Dufour C
Br J Haematol; 2011 Apr; 153(2):279-82. PubMed ID: 21275956
[No Abstract] [Full Text] [Related]
8. Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
Aricò M; Germano G; del Giudice L; Ziino O; Locatelli F; Basso G
Haematologica; 2002 Apr; 87(4):ELT19. PubMed ID: 11940504
[No Abstract] [Full Text] [Related]
9. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
[TBL] [Abstract][Full Text] [Related]
10. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant minimal residual disease in children with acute lymphoblastic leukemia.
Mehta PA; Davies SM
Pediatr Blood Cancer; 2007 Jan; 48(1):1-2. PubMed ID: 16642487
[No Abstract] [Full Text] [Related]
12. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
[TBL] [Abstract][Full Text] [Related]
13. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
[TBL] [Abstract][Full Text] [Related]
14. Application of a chemiluminescent methodology for detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Lo Nigro L; Poli A; Mirabile E; Costantino F; Schilirò G
Haematologica; 2001 Dec; 86(12):1314-6. PubMed ID: 11726326
[No Abstract] [Full Text] [Related]
15. Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group.
Krejci O; van der Velden VH; Bader P; Kreyenberg H; Goulden N; Hancock J; Schilham MW; Lankester A; Révész T; Klingebiel T; van Dongen JJ
Bone Marrow Transplant; 2003 Oct; 32(8):849-51. PubMed ID: 14520434
[No Abstract] [Full Text] [Related]
16. Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Buldini B; Zangrando A; Michielotto B; Veltroni M; Giarin E; Tosato F; Cazzaniga G; Biondi A; Basso G
Am J Hematol; 2010 Feb; 85(2):138-41. PubMed ID: 20095033
[No Abstract] [Full Text] [Related]
17. Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre.
Motwani J; Jesson J; Sturch E; Jones S; Eyre L; Short P; Davies P; Williams MD; Darbyshire PJ; Hill FG; Lawson S
Br J Haematol; 2009 Jan; 144(1):133-5. PubMed ID: 19016737
[No Abstract] [Full Text] [Related]
18. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
Magyarosy E; Varga N; Timár J; Rásó E
Pediatr Hematol Oncol; 2003; 20(1):65-74. PubMed ID: 12687755
[TBL] [Abstract][Full Text] [Related]
19. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
[TBL] [Abstract][Full Text] [Related]
20. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL
Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]